Sven Zimmermann

Biochemistry, Genetics and Molecular Biology · Life Sciences

7h-index2.5kcitations7works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Kinase Regulation and GTPase Signaling(4), PI3K/AKT/mTOR signaling in cancer(4), Melanoma and MAPK Pathways(2), T-cell and B-cell Immunology(1), Cancer Immunotherapy and Biomarkers(1)

Publications7 total

The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns
Epigenetics·2013· 21 citedOpen Access
A WD-FYVE protein binds to the kinases Akt and PKCζ/λ
Biochemical Journal·2006· 35 citedOpen Access
Regulation of Raf-Akt Cross-talk
Journal of Biological Chemistry·2002· 383 citedOpen Access
Regulation of Raf by Akt Controls Growth and Differentiation in Vascular Smooth Muscle Cells
Journal of Biological Chemistry·2001· 157 citedOpen Access
Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt
Science·1999· 766 cited
Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)
Science·1999· 1.1k cited
MEK1 mediates a positive feedback on Raf-1 activity independently of Ras and Src
Oncogene·1997· 33 cited

Frequent Co-authors

Karin Moelling(6), Christian Rommel(2), Magnus Bosse(2), Marc Schweneker(2), Brian Clarke(1), Lorna Nuñez(1), Roni Rossman(1), Kristina Reid(1), George D. Yancopoulos(1), David J. Glass(1), Karen Schad(1), H. Peter Reusch(1), Michael Schaefer(1), Martin Paul(1), Thorsten Fritzius(1), Guido Burkard(1), Elvira Haas(1), Jochen Heinrich(1), Alexander D. Frey(1), Antje Caelers(1)